Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 14

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  protein tyrosine kinase
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Isoflavonoids and their 3' and 4'-O-substitued derivatives as inhibitors of SH2 domain of p56 protein tyrosine kinase

100%
Godlewska A., Augustyniak R., Bodera P.
Cellular and Molecular Biology Letters
|
2005
|
tom 10
|
nr Suppl.2
2

Dissecting the functions of protein tyrosine phosphatases using chemical approaches

100%
Zhang Z. Y.
Cellular and Molecular Biology Letters
|
2005
|
tom 10
|
nr Suppl.2
3

Chemical approaches to the study of protein tyrosine kinases and their implications for mechanism and inhibitor design

100%
Cole P. A.
Cellular and Molecular Biology Letters
|
1998
|
tom 03
|
nr 3
4

The association of activated receptor Fc gamma II with plasma membrane rafts, revealed by confocal and immunoelectron microscopy

88%
Strzelecka-Kiliszek A., Kwiatkowska K., Shakor A. B. A., Sobota A.
Cellular and Molecular Biology Letters
|
2002
|
tom 07
|
nr Suppl.
5

Application of aptamers for targeted therapeutics

63%
Ray P., Viles K. D., Soule E. E., Woodruff R. S.
Archivum Immunologiae et Therapiae Experimentalis
|
2013
|
tom 61
|
nr 4
6
Content available remote

Genistein and daidzein affect in vitro steroidogenesis but not gene expression of steroidogenic enzymes in adrenals of pigs

63%
Kaminska B., Czerwinska J., Wojciechowicz B., Nynca A., Ciereszko R.
Journal of Physiology and Pharmacology
|
2014
|
tom 65
|
nr 1
7
Content available remote

Angiotensin IV stimulates the activity of tyrosine kinases in rat anterior pituitary gland acting via AT1-like receptors?

63%
Rebas E., Lachowicz-Ochedalska A., Pawlikowski M.
Journal of Physiology and Pharmacology
|
2004
|
tom 55
|
nr 1,1
Angiotensin II (Ang II) is known to modulate tyrosine kinases (PTKs) activity in pituitary tumor cells. It is known that AngII is acting via AT1 receptors in many tissues. The aim of this study was to see whether 3-8 fragment of AngII, called angiotensin IV (AngIV) has a similar effect on tyrosine kinase activity in normal pituitary gland and what type of angiotensin receptor is involved in this process. The homogenates of normal rat pituitaries was a source of enzymes. The PTKs activity was determined using the synthetic substrate poly GluTyr and -32P-ATP. Ang IV was found to increase the PTK activity in the rat anterior pituitary tissue, with the maximal effect at concentration of 10-10M. AngII was ineffective at all concentrations studied. Losartan, a selective AT1 receptor blocker, added together with Ang IV abolished the effect of the latter, however losartan diminished also the PTK activity when applied together with Ang II, but only when it was added immediately before, but not after, the addition of Ang II. The involvement of a non-classic AT1-like receptor is suggested.
8

Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia

63%
Bojarska-Junak A., Rolinski J., Kawiak J.
Folia Histochemica et Cytobiologica
|
2005
|
tom 43
|
nr 1
9

Liposomal imatinib: an EPR and DSC study

51%
Beni S., Budai M., Noszal B., Grof P.
Cellular and Molecular Biology Letters
|
2005
|
tom 10
|
nr Suppl.
10
Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik
Content available

Effect of genistein, tyrphostin and herbimycin on prolactin-stimulated progesterone production by porcine theca and luteal cells

51%
Gregoraszczuk E., Slomczynska M., Stoklosowa S.
Journal of Physiology and Pharmacology
|
1999
|
tom 50
|
nr 3
11

Modelling of insulin receptor tyrosine kinase in its active form: a case study for validation of theoretical methods

51%
Ginalski K., Wojciechowski M., Lesyng B.
Acta Biochimica Polonica
|
1999
|
tom 46
|
nr 3
An active form of an insulin receptor tyrosine kinase (IRK) catalytic core was modelled based on its experimentally known inactive form and the active form of a serine/threonine kinase, protein kinase A (PKA). This theoretical model was compared with the crystallographic structure of the active form of IRK reported later. The structures are very similar, which shows that all the most important features and interactions have been taken into account in the modelling procedure. The elaborated procedure can be applied to other tyrosine kinases. This would allow designing of a wide class of tyrosine kinase inhibitors, very important potential anti-cancer and/or anti-viral drugs.
12

Insulin-like growth factor-1 initiates a negative feed back mechanism by JNK activated SHP1 to regulate proliferation of breast cancer cells

51%
Amin S., Kumar A., Lee J., Kozlowski M.
Cellular and Molecular Biology Letters
|
2005
|
tom 10
|
nr Suppl.2
13

Structure-based design of the antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione TX-1123 as a protein tyrosine kinase inhibitor having low mitochondrial toxicity

51%
Hori H., Nagasawa H., Uto Y.
Cellular and Molecular Biology Letters
|
2003
|
tom 08
|
nr 2A
14

MAPK regulation of gene expression in the central nervous system

38%
Adams J. P., Roberson E. D., English J. D., Selcher J. C., Sweatt J. D.
Acta Neurobiologiae Experimentalis
|
2000
|
tom 60
|
nr 3
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.